路透 - 视频

版本: US | UK | IN | CN | JP

video

Breakingviews TV: Pill popping

2019年 11月 1日 星期五 - 03:21

Nov 1 - Pharma giant Amgen is buying a fifth of China biotech star BeiGene for $2.7 bln. A 36% premium seems steep when the target has just shaken off a short-seller attack. But it’s a chance to crack a growing market for cancer drugs, Katrina Hamlin tells Pete Sweeney.

▲ 隐藏详情

显示详情

Nov 1 - Pharma giant Amgen is buying a fifth of China biotech star BeiGene for $2.7 bln. A 36% premium seems steep when the target has just shaken off a short-seller attack. But it’s a chance to crack a growing market for cancer drugs, Katrina Hamlin tells Pete Sweeney.

分享到  - 微信
路透中文网

Breakingviews TV: Pill popping

2019年 11月 1日 星期五 - 03:21